Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lower Protamine Dose for Reversal of Heparin After Cardiopulmonary Bypass: Is it Safe? Comparative Prospective Randomized Trial.

NCT07477977 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07477977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07477977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lower Protamine Dose for Reversal of Heparin After Cardiopulmonary Bypass: Is it Safe? Comparative Prospective Randomized Trial.
Lead sponsor
Sohag University
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2026
Completion date
September 1, 2026
Enrollment
195 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

open heart surgery